E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/15/2023 in the Prospect News Convertibles Daily and Prospect News Liability Management Daily.

Sosei buys back ¥29.85 billion of 0.25% convertible bonds due 2026

By Marisa Wong

Los Angeles, Dec. 15 – Sosei Group Corp. repurchased ¥29.85 billion of its 0.25% convertible bonds due 2026 (ISIN: XS2363140810) as of Dec. 14, according to a company announcement.

The repurchased bonds will be canceled.

As of Dec. 15, ¥150 million of the principal amount remains outstanding.

In a previous announcement, the company said it would repurchase any and all of the bonds. The buyback was to occur concurrently with the company’s issuance of ¥32 billion of 0.25% convertible bonds due 2028.

The biopharmaceutical group is based in Tokyo and has research facilities in Cambridge, England. Its corporate brand and trademark is Sosei Heptares.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.